By Julia Luke
A crashed shopping app is an inconvenience. A crashed medication-tracking app, at the wrong moment, is something else entirely. That difference in stakes is the reason healthtech software development keeps its own set of rules, and why a team that builds it well tends to think about a project quite differently from one building a typical business app.
Key Takeaways
- Healthtech software carries patient safety consequences that ordinary business software doesn’t, which changes how much testing, documentation, and clinical input a build actually needs before release.
- Regulatory classification under UK medical device rules depends on what the software actually does, not what it’s called, and getting this wrong can mean a product is built to the wrong standard from day one.
- Accessibility in health software is rarely optional, because the people using it are disproportionately likely to have a condition affecting sight, dexterity, or cognitive load.
- Offline-first design matters more in healthtech than most sectors, since a connectivity gap during a health-related task can have real consequences rather than just an inconvenience.
- Interoperability with existing NHS and care systems is usually a harder problem than the clinical logic itself, and it needs planning from the first specification, not retrofitting later.
Most software development treats a bug as something to fix in the next release. Healthtech treats certain bugs as something to have prevented from ever reaching a user, because the cost of getting it wrong isn’t a bad review, it’s a patient outcome. That single shift in what “acceptable risk” means underpins almost every other difference in how these products get built.
Regulation depends on function, not branding
A common misunderstanding is that “health app” and “medical device” are separate categories a developer can choose between. In the UK, that isn’t how the rules work. The Medicines and Healthcare products Regulatory Agency classifies software based on what it actually does: an app that calculates a dosage or interprets a diagnostic result behaves differently, in regulatory terms, from one that simply reminds someone to take medication they’ve already been prescribed.
Getting this classification wrong early is expensive. A product built as a simple wellness tool, then discovered to function as a medical device once a clinical claim gets added, often has to be rebuilt against a documentation and testing standard it was never designed to meet. Working out the classification before writing a line of code, not after a pilot, is one of the clearest markers of a team that has actually built in this space before.
A clinician reviewing patient information on a tablet device
Safety-critical thinking changes the development process itself
In most software projects, a bug found in testing gets triaged, prioritised, and scheduled. In healthtech, the more important question comes earlier: what happens if this exact bug reaches a real patient before anyone catches it? That question forces a different development rhythm: more structured clinical input during design, more rigorous test coverage around anything touching a dosage, an alert, or a diagnosis-adjacent output, and audit trails that can reconstruct exactly what a user saw and when.
NHS Digital’s own guidance for digital health tools reflects this directly, treating clinical safety as a discipline that runs alongside the engineering work rather than a sign-off at the end of it. NICE has built an entire evidence standards framework, first published in 2019, specifically because a plausible-sounding health app and a genuinely effective one are not the same thing, and telling them apart requires more than a demo.
Software that touches a clinical decision has to be built as if the worst-case bug will eventually happen, not as if it probably won’t.
Accessibility isn’t a nice-to-have here
Health software’s actual user base skews heavily toward people managing a condition that affects sight, dexterity, fine motor control, or cognitive load, sometimes all at once. A crisis-mode interface designed for someone in acute distress needs different defaults entirely from a general consumer app: fewer steps to a core action, higher contrast by default, and no assumption that the user has full attention or patience to spare.
The Professional Record Standards Body, which sets UK standards for how health and care information is recorded and shared, has pushed for exactly this kind of design discipline in clinical software, because inconsistent or inaccessible interfaces don’t just frustrate users, they introduce a genuine safety gap when the wrong information gets missed or misread under pressure.
A care worker checking in with an older patient at their bedside
Offline and low-connectivity design is a real requirement, not a fallback
A support app that only works with a live connection fails exactly when it’s needed most: during a crisis, in a rural area, or on a device with patchy signal in a hospital corridor. Logging a symptom, a fall, or a near-miss offline and syncing later isn’t a technical nicety in this sector, it’s often the difference between a tool someone actually uses and one they abandon after the first failed attempt.
Arch, a UK software development company, built exactly this pattern into iFell, an app supporting people with Parkinson’s to log falls and near-misses, which needed offline logging and cross-platform support to reach patients reliably regardless of connection. The same principle shaped Turning Point, a harm-reduction app built with no account creation and a deliberately simple crisis-mode interface, meeting the WCAG 2.2 AA accessibility standard, published as a W3C Recommendation in 2023, because the people using it needed the lowest possible barrier to getting help.
Interoperability is usually the hardest part
The clinical logic in a piece of health software is often the easier half of the build. Making that software talk to the systems already in place, NHS Spine connections, existing patient record formats, a hospital’s own scheduling or radiology systems, tends to be the harder and less glamorous problem, and one that has to be scoped from the first specification rather than discovered mid-project.
Radarr Medical, an NHS radiology communications platform recognised as an NHS-X Winner, is a useful example of why this matters: the value of a clinical tool depends heavily on how cleanly it fits into workflows and systems that already exist, not just on how well its own interface works in isolation. A product that ignores this and treats interoperability as an afterthought usually ends up needing a second, more expensive build to fix it.
Frequently Asked Questions
Does every health-related app count as a medical device in the UK?
No. The MHRA classifies software based on its actual function, not its marketing description. An app that simply reminds a patient to take medication is treated differently from one that calculates a dose or interprets a result, so classification has to be worked out early against what the software genuinely does.
Why does healthtech software need more testing than a typical business app?
Because certain failures carry a direct patient safety risk rather than just an inconvenience or lost revenue. This shifts testing toward preventing rare but serious failures, not just fixing common ones quickly, and usually involves clinical input alongside the engineering work rather than after it.
What does offline-first mean in a health app context?
It means the software can log information, such as a symptom, dose, or incident, without an active internet connection, then sync once connectivity returns. This matters because many health-related tasks happen in exactly the settings where connectivity is least reliable.
Why is interoperability harder than the clinical logic itself?
Existing NHS and care systems weren’t necessarily built to share data with new software, so a new tool has to adapt to established formats and workflows rather than the reverse. This work is often underestimated at the specification stage and becomes expensive to retrofit later.
How does accessibility affect safety in clinical software?
Health software users are disproportionately likely to have a condition affecting sight, dexterity, or cognitive load, so an inaccessible interface isn’t just an inconvenience, it can mean critical information gets missed or misread. Building accessibility in from the start reduces that risk rather than patching it in afterwards.
Sources
- Digital.NHS.UK
- Medicines and Healthcare products Regulatory Agency
- Professional Record Standards Body
- W3C: Web Content Accessibility Guidelines (WCAG) 2.2, a W3C Recommendation (2023)
- Black, “The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview,” PLoS Medicine (2011)
